Key regions: China, Europe, Australia, United States, Germany
The Other Pharmaceuticals market in Greece has been experiencing interesting developments in recent years.
Customer preferences: Customers in Greece have been increasingly interested in alternative and complementary medicines, leading to a rise in demand for Other Pharmaceuticals. This trend is in line with global preferences, where consumers are seeking more natural and holistic remedies for their health issues.
Trends in the market: The Other Pharmaceuticals market in Greece has been growing steadily due to the increasing demand for natural and alternative medicines. In addition, the rise in health consciousness and awareness has also contributed to the growth of this market. Consumers are looking for products that are safe, effective, and have fewer side effects than traditional medicines. As a result, companies are investing in research and development to create innovative products that meet these demands.
Local special circumstances: Greece has a rich history of traditional medicine, which has contributed to the popularity of alternative medicines in the country. Additionally, the economic crisis in Greece has led to a decline in the use of traditional medicines due to their high cost. This has further fueled the demand for alternative medicines, including Other Pharmaceuticals.
Underlying macroeconomic factors: The Greek economy has been struggling in recent years, leading to a decline in the overall pharmaceutical market. However, the Other Pharmaceuticals market has been able to withstand these challenges due to its unique position as a natural and alternative medicine market. Additionally, the Greek government has been supportive of the development of this market, providing incentives for companies to invest in research and development.In conclusion, the Other Pharmaceuticals market in Greece has been growing due to the increasing demand for natural and alternative medicines. This trend is in line with global preferences, and has been further fueled by the economic crisis in Greece. Companies are investing in research and development to create innovative products that meet the demands of consumers. The Greek government has been supportive of this market, providing incentives for companies to invest in this sector.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
